

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.08498323 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.08498323 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.83462594 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71675013 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.41805555 |
| 6 | viral transcription (GO:0019083) | 4.32199211 |
| 7 | GDP-mannose metabolic process (GO:0019673) | 4.28319752 |
| 8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.23477600 |
| 9 | translational termination (GO:0006415) | 4.12977852 |
| 10 | protein maturation by protein folding (GO:0022417) | 4.04299429 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68442617 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 3.66386466 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 3.66386466 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.65335963 |
| 15 | translational elongation (GO:0006414) | 3.64476845 |
| 16 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58399130 |
| 17 | protein targeting to ER (GO:0045047) | 3.55013099 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 3.52880026 |
| 19 | ribosomal small subunit biogenesis (GO:0042274) | 3.37743369 |
| 20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.37029547 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.36346345 |
| 22 | viral life cycle (GO:0019058) | 3.34756792 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32743360 |
| 24 | protein localization to endoplasmic reticulum (GO:0070972) | 3.31324241 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.29041786 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.23197230 |
| 27 | regulation of protein heterodimerization activity (GO:0043497) | 3.18758114 |
| 28 | cellular protein complex disassembly (GO:0043624) | 3.16972746 |
| 29 | negative regulation of phagocytosis (GO:0050765) | 3.15573686 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13639821 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.11520974 |
| 32 | actin nucleation (GO:0045010) | 3.09752721 |
| 33 | translational initiation (GO:0006413) | 3.08853065 |
| 34 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03909571 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 2.99878355 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96903770 |
| 37 | leukocyte aggregation (GO:0070486) | 2.95874218 |
| 38 | T cell apoptotic process (GO:0070231) | 2.94231903 |
| 39 | regulation of metalloenzyme activity (GO:0048552) | 2.93604987 |
| 40 | hepatocyte apoptotic process (GO:0097284) | 2.92528372 |
| 41 | maturation of SSU-rRNA (GO:0030490) | 2.90724199 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.88903864 |
| 43 | response to interferon-beta (GO:0035456) | 2.84805369 |
| 44 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.83567775 |
| 45 | DNA deamination (GO:0045006) | 2.82541487 |
| 46 | protein complex disassembly (GO:0043241) | 2.81929249 |
| 47 | membrane raft organization (GO:0031579) | 2.81693467 |
| 48 | positive regulation of lamellipodium assembly (GO:0010592) | 2.80466404 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80317361 |
| 50 | regulation of superoxide anion generation (GO:0032928) | 2.80233274 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79987838 |
| 52 | B cell mediated immunity (GO:0019724) | 2.78621752 |
| 53 | establishment of viral latency (GO:0019043) | 2.75578657 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.73806869 |
| 55 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.69722002 |
| 56 | negative regulation of ligase activity (GO:0051352) | 2.69722002 |
| 57 | regulation of B cell differentiation (GO:0045577) | 2.67622263 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.65729905 |
| 59 | positive regulation of macrophage differentiation (GO:0045651) | 2.65659789 |
| 60 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.65047000 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.64044333 |
| 62 | proteasome assembly (GO:0043248) | 2.63756235 |
| 63 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.62302407 |
| 64 | endothelial tube morphogenesis (GO:0061154) | 2.61316882 |
| 65 | morphogenesis of an endothelium (GO:0003159) | 2.61316882 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 2.60257911 |
| 67 | macromolecular complex disassembly (GO:0032984) | 2.60090094 |
| 68 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.59507073 |
| 69 | mannose metabolic process (GO:0006013) | 2.59116541 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 2.59052404 |
| 71 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.58970004 |
| 72 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.58965798 |
| 73 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.58965798 |
| 74 | sequestering of actin monomers (GO:0042989) | 2.58925048 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58294632 |
| 76 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.57535990 |
| 77 | modulation by symbiont of host immune response (GO:0052553) | 2.57535990 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 2.57535990 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 2.57535990 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.57535990 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.57535990 |
| 82 | lymphocyte apoptotic process (GO:0070227) | 2.57239288 |
| 83 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.56733441 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 2.54459662 |
| 85 | response to type I interferon (GO:0034340) | 2.54441614 |
| 86 | positive regulation of lamellipodium organization (GO:1902745) | 2.53882250 |
| 87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.53354208 |
| 88 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.53354208 |
| 89 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.53354208 |
| 90 | response to interferon-alpha (GO:0035455) | 2.52396419 |
| 91 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.52111711 |
| 92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51441658 |
| 93 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.51258053 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50548302 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50480158 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.49888778 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.49888778 |
| 98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.49437935 |
| 99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.49437935 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.49342608 |
| 101 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.49111616 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.48930025 |
| 103 | mature B cell differentiation involved in immune response (GO:0002313) | 2.48470970 |
| 104 | DNA unwinding involved in DNA replication (GO:0006268) | 2.46796411 |
| 105 | pinocytosis (GO:0006907) | 2.46129962 |
| 106 | formation of translation preinitiation complex (GO:0001731) | 2.45408888 |
| 107 | protein targeting to membrane (GO:0006612) | 2.45171114 |
| 108 | DNA strand elongation (GO:0022616) | 2.45007270 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 2.44748989 |
| 110 | pentose-phosphate shunt (GO:0006098) | 2.44228203 |
| 111 | establishment of integrated proviral latency (GO:0075713) | 2.43858023 |
| 112 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.42390680 |
| 113 | regulation of interferon-alpha production (GO:0032647) | 2.41895415 |
| 114 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.39710449 |
| 115 | regulation of necroptotic process (GO:0060544) | 2.38772988 |
| 116 | definitive hemopoiesis (GO:0060216) | 2.38039802 |
| 117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.38015346 |
| 118 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.37104453 |
| 119 | leukocyte cell-cell adhesion (GO:0007159) | 2.35831821 |
| 120 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.34768293 |
| 121 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.34164785 |
| 122 | NADPH regeneration (GO:0006740) | 2.33201215 |
| 123 | response to protozoan (GO:0001562) | 2.32826336 |
| 124 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.32483061 |
| 125 | positive thymic T cell selection (GO:0045059) | 2.32392831 |
| 126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.32310773 |
| 127 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.30636634 |
| 128 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.29833289 |
| 129 | cellular response to zinc ion (GO:0071294) | 2.29282202 |
| 130 | cellular response to interferon-beta (GO:0035458) | 2.29278966 |
| 131 | response to peptidoglycan (GO:0032494) | 2.28052085 |
| 132 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.28009369 |
| 133 | telomere maintenance via recombination (GO:0000722) | 2.27901480 |
| 134 | oligosaccharide catabolic process (GO:0009313) | 2.27642665 |
| 135 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.26913780 |
| 136 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.26192923 |
| 137 | lipopolysaccharide metabolic process (GO:0008653) | 2.25546369 |
| 138 | positive regulation of ligase activity (GO:0051351) | 2.24956712 |
| 139 | mRNA catabolic process (GO:0006402) | 2.24552189 |
| 140 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.24221171 |
| 141 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.24221171 |
| 142 | T cell homeostasis (GO:0043029) | 2.23972375 |
| 143 | negative regulation of stress fiber assembly (GO:0051497) | 2.23603676 |
| 144 | chaperone-mediated protein transport (GO:0072321) | 2.23509827 |
| 145 | glucose catabolic process (GO:0006007) | 2.23029667 |
| 146 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.22861284 |
| 147 | negative regulation of viral genome replication (GO:0045071) | 2.22781568 |
| 148 | regulation of response to interferon-gamma (GO:0060330) | 2.22563809 |
| 149 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.22431406 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.21747158 |
| 151 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.21283476 |
| 152 | ribosomal large subunit biogenesis (GO:0042273) | 2.19183379 |
| 153 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.19041502 |
| 154 | myeloid dendritic cell activation (GO:0001773) | 2.18635698 |
| 155 | mitotic nuclear envelope reassembly (GO:0007084) | 2.17922649 |
| 156 | nuclear envelope reassembly (GO:0031468) | 2.17922649 |
| 157 | purine-containing compound salvage (GO:0043101) | 2.17650810 |
| 158 | leukocyte apoptotic process (GO:0071887) | 2.17325873 |
| 159 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.17145181 |
| 160 | fibril organization (GO:0097435) | 2.16562420 |
| 161 | glycosphingolipid catabolic process (GO:0046479) | 2.16144080 |
| 162 | regulation of mast cell degranulation (GO:0043304) | 2.13529103 |
| 163 | pentose metabolic process (GO:0019321) | 2.09910831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.76586343 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18092195 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05246833 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.94027901 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.64103026 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56839821 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.55361690 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.47502912 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43546617 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42326046 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.39622776 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37082397 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.36252930 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32237653 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.21039459 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20770291 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13939541 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11497879 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06783496 |
| 20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06626086 |
| 21 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04877799 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00288323 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99758165 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99494940 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91725056 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89378287 |
| 27 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.88648845 |
| 28 | * MAF_26560356_Chip-Seq_TH1_Human | 1.87080450 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84378039 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84269320 |
| 31 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82275832 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 1.79217862 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78531761 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.77765865 |
| 35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.73592745 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72791344 |
| 37 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72371567 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71969456 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.71711888 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71489594 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.70791571 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70281886 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70211756 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68961240 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65099285 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61894942 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61723229 |
| 48 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61713229 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60453106 |
| 50 | * MYB_26560356_Chip-Seq_TH1_Human | 1.52175985 |
| 51 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48429723 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47480563 |
| 53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45147984 |
| 54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.44619166 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.43064640 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42169823 |
| 57 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42165076 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42074015 |
| 59 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41894877 |
| 60 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.41628198 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39387257 |
| 62 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.37878292 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37549547 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35268460 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33598338 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32780565 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32777537 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32469330 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32087774 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31810459 |
| 71 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31124019 |
| 72 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.29647897 |
| 73 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29280650 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28192197 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27877944 |
| 76 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.26306588 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26093346 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26055188 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25812444 |
| 80 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24418337 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23340978 |
| 82 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23173145 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.22898144 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21866442 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21358129 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21210822 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19867532 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17367807 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17005091 |
| 90 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16861165 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16211092 |
| 92 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16135026 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15582323 |
| 94 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13862571 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13219391 |
| 96 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.12564112 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11365332 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09599253 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09551768 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08835033 |
| 101 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08826047 |
| 102 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07651808 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07470652 |
| 104 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06607407 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06508612 |
| 106 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05789980 |
| 107 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.05294327 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03703377 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02986659 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02528819 |
| 111 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02063021 |
| 112 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01038208 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99552532 |
| 114 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99531764 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98470797 |
| 116 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98424222 |
| 117 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97624488 |
| 118 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97040305 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95411677 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95079359 |
| 121 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94858716 |
| 122 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94857591 |
| 123 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93699860 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92969819 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92888664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.10851593 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 2.63910753 |
| 3 | MP0000685_abnormal_immune_system | 2.57782095 |
| 4 | MP0003436_decreased_susceptibility_to | 2.51850493 |
| 5 | MP0009785_altered_susceptibility_to | 2.44131083 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.40278037 |
| 7 | MP0005671_abnormal_response_to | 2.30514487 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.21519462 |
| 9 | MP0001800_abnormal_humoral_immune | 2.16504506 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.12773332 |
| 11 | MP0006054_spinal_hemorrhage | 2.11817579 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.11531400 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.11204367 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.10753350 |
| 15 | MP0005025_abnormal_response_to | 2.06852638 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.05545866 |
| 17 | MP0005451_abnormal_body_composition | 2.03051548 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.01366715 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.99501360 |
| 20 | MP0001819_abnormal_immune_cell | 1.97787687 |
| 21 | MP0001790_abnormal_immune_system | 1.96760932 |
| 22 | MP0005387_immune_system_phenotype | 1.96760932 |
| 23 | MP0003303_peritoneal_inflammation | 1.94856529 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.93079638 |
| 25 | * MP0002398_abnormal_bone_marrow | 1.92807643 |
| 26 | MP0002723_abnormal_immune_serum | 1.91591467 |
| 27 | MP0002419_abnormal_innate_immunity | 1.91163818 |
| 28 | MP0008260_abnormal_autophagy | 1.90716883 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.90236731 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.90236731 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.89365186 |
| 32 | MP0000490_abnormal_crypts_of | 1.88387844 |
| 33 | MP0002405_respiratory_system_inflammati | 1.84103634 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.81315804 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.81012154 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.77106663 |
| 37 | MP0004947_skin_inflammation | 1.75289067 |
| 38 | * MP0005464_abnormal_platelet_physiology | 1.73958190 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.72612819 |
| 40 | MP0000858_altered_metastatic_potential | 1.68893042 |
| 41 | MP0000716_abnormal_immune_system | 1.68725507 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.68078510 |
| 43 | MP0002722_abnormal_immune_system | 1.67665660 |
| 44 | MP0009278_abnormal_bone_marrow | 1.67242396 |
| 45 | MP0003724_increased_susceptibility_to | 1.64025540 |
| 46 | MP0001873_stomach_inflammation | 1.62521899 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.59702691 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.57582894 |
| 49 | * MP0002429_abnormal_blood_cell | 1.54839499 |
| 50 | MP0001853_heart_inflammation | 1.54622252 |
| 51 | MP0005165_increased_susceptibility_to | 1.54485278 |
| 52 | MP0006082_CNS_inflammation | 1.53281045 |
| 53 | MP0005023_abnormal_wound_healing | 1.51937333 |
| 54 | MP0003075_altered_response_to | 1.50459227 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.49216477 |
| 56 | MP0002006_tumorigenesis | 1.47769436 |
| 57 | MP0002933_joint_inflammation | 1.44851305 |
| 58 | MP0008007_abnormal_cellular_replicative | 1.44581423 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.41108922 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.38270356 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.34113493 |
| 62 | MP0010307_abnormal_tumor_latency | 1.33614835 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 1.32295982 |
| 64 | MP0003866_abnormal_defecation | 1.32226291 |
| 65 | MP0003279_aneurysm | 1.31257585 |
| 66 | MP0009764_decreased_sensitivity_to | 1.29784535 |
| 67 | MP0003950_abnormal_plasma_membrane | 1.28162557 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.27342919 |
| 69 | MP0000343_altered_response_to | 1.26583252 |
| 70 | MP0003448_altered_tumor_morphology | 1.26555242 |
| 71 | MP0005083_abnormal_biliary_tract | 1.25715655 |
| 72 | MP0003077_abnormal_cell_cycle | 1.23276814 |
| 73 | MP0001542_abnormal_bone_strength | 1.20021810 |
| 74 | MP0003186_abnormal_redox_activity | 1.19818237 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.15895780 |
| 76 | MP0003786_premature_aging | 1.13215078 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.10199328 |
| 78 | MP0005360_urolithiasis | 1.05865869 |
| 79 | MP0005164_abnormal_response_to | 1.05182489 |
| 80 | MP0001727_abnormal_embryo_implantation | 1.04139559 |
| 81 | MP0001958_emphysema | 1.03792625 |
| 82 | MP0003111_abnormal_nucleus_morphology | 1.03256250 |
| 83 | MP0008469_abnormal_protein_level | 1.02245518 |
| 84 | MP0010094_abnormal_chromosome_stability | 1.01468774 |
| 85 | MP0009763_increased_sensitivity_to | 1.00944088 |
| 86 | MP0004272_abnormal_basement_membrane | 0.97359322 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.95874502 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.95714498 |
| 89 | MP0005166_decreased_susceptibility_to | 0.94839035 |
| 90 | MP0005275_abnormal_skin_tensile | 0.92031031 |
| 91 | MP0002132_abnormal_respiratory_system | 0.91091609 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.90489890 |
| 93 | MP0000477_abnormal_intestine_morphology | 0.89860726 |
| 94 | MP0003828_pulmonary_edema | 0.87712893 |
| 95 | MP0005390_skeleton_phenotype | 0.87601832 |
| 96 | MP0004510_myositis | 0.85990392 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.83171623 |
| 98 | MP0005501_abnormal_skin_physiology | 0.83080391 |
| 99 | MP0001881_abnormal_mammary_gland | 0.82868187 |
| 100 | MP0000313_abnormal_cell_death | 0.82341932 |
| 101 | MP0003091_abnormal_cell_migration | 0.82216455 |
| 102 | MP0000358_abnormal_cell_content/ | 0.81907025 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.81177538 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.79204179 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.78339149 |
| 106 | MP0000609_abnormal_liver_physiology | 0.77844691 |
| 107 | MP0003795_abnormal_bone_structure | 0.77708871 |
| 108 | MP0005310_abnormal_salivary_gland | 0.76919495 |
| 109 | MP0001849_ear_inflammation | 0.76651652 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.75771980 |
| 111 | MP0002060_abnormal_skin_morphology | 0.75363856 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.75339916 |
| 113 | MP0001243_abnormal_dermal_layer | 0.74950619 |
| 114 | MP0001915_intracranial_hemorrhage | 0.72970695 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.71751871 |
| 116 | MP0001851_eye_inflammation | 0.71058421 |
| 117 | MP0000249_abnormal_blood_vessel | 0.70716907 |
| 118 | MP0000733_abnormal_muscle_development | 0.70559581 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.68553402 |
| 120 | MP0001663_abnormal_digestive_system | 0.68305629 |
| 121 | MP0009840_abnormal_foam_cell | 0.66141309 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.65360482 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.64134528 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 0.63429467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04439500 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.85308730 |
| 3 | Thrombocytosis (HP:0001894) | 3.66800448 |
| 4 | Petechiae (HP:0000967) | 3.62525010 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.58132953 |
| 6 | Chronic otitis media (HP:0000389) | 3.50969375 |
| 7 | Myositis (HP:0100614) | 3.43312292 |
| 8 | Hypertensive crisis (HP:0100735) | 3.38704121 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.34630433 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.34630433 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.34630433 |
| 12 | IgM deficiency (HP:0002850) | 3.24729628 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.20757880 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.12699026 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.10287733 |
| 16 | Cellulitis (HP:0100658) | 3.03949234 |
| 17 | Reticulocytopenia (HP:0001896) | 3.03867506 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.03750330 |
| 19 | Interstitial pulmonary disease (HP:0006530) | 2.99255680 |
| 20 | Cholecystitis (HP:0001082) | 2.98710624 |
| 21 | Abnormal gallbladder physiology (HP:0012438) | 2.98710624 |
| 22 | Recurrent viral infections (HP:0004429) | 2.92518619 |
| 23 | Hepatosplenomegaly (HP:0001433) | 2.89023531 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.86757752 |
| 25 | Nasal polyposis (HP:0100582) | 2.86138030 |
| 26 | Pustule (HP:0200039) | 2.84813053 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 2.84182455 |
| 28 | Protrusio acetabuli (HP:0003179) | 2.80454856 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.74590740 |
| 30 | Rough bone trabeculation (HP:0100670) | 2.74038838 |
| 31 | Amyloidosis (HP:0011034) | 2.71741353 |
| 32 | Increased IgM level (HP:0003496) | 2.58899400 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.58690780 |
| 34 | Cervical subluxation (HP:0003308) | 2.57385378 |
| 35 | Increased serum ferritin (HP:0003281) | 2.53322879 |
| 36 | Increased density of long bones (HP:0006392) | 2.52185996 |
| 37 | Abnormality of T cells (HP:0002843) | 2.44589101 |
| 38 | Abnormal platelet function (HP:0011869) | 2.44425137 |
| 39 | Impaired platelet aggregation (HP:0003540) | 2.44425137 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.43751004 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.41857218 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.39514351 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.37448729 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.35088680 |
| 45 | Aplastic anemia (HP:0001915) | 2.30327097 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.30222592 |
| 47 | Myocardial infarction (HP:0001658) | 2.30205797 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.28293915 |
| 49 | Pallor (HP:0000980) | 2.28166652 |
| 50 | Orchitis (HP:0100796) | 2.27816923 |
| 51 | Meningitis (HP:0001287) | 2.27698310 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.21913484 |
| 53 | Recurrent skin infections (HP:0001581) | 2.19700242 |
| 54 | Abnormal platelet volume (HP:0011876) | 2.18917097 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.17808085 |
| 56 | Osteolytic defects of the hand bones (HP:0009699) | 2.16558994 |
| 57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16558994 |
| 58 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.16554164 |
| 59 | Orthostatic hypotension (HP:0001278) | 2.15278345 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.14977472 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14964356 |
| 62 | Abnormal trabecular bone morphology (HP:0100671) | 2.14939486 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14270916 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.13848741 |
| 65 | Lymphopenia (HP:0001888) | 2.12870148 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.12505253 |
| 67 | Osteomyelitis (HP:0002754) | 2.11374313 |
| 68 | Obstructive lung disease (HP:0006536) | 2.09725233 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09725233 |
| 70 | Leukocytosis (HP:0001974) | 2.08828027 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08766684 |
| 72 | Urticaria (HP:0001025) | 2.08366835 |
| 73 | Skin ulcer (HP:0200042) | 2.05323098 |
| 74 | Seborrheic dermatitis (HP:0001051) | 2.03965877 |
| 75 | T lymphocytopenia (HP:0005403) | 2.01740646 |
| 76 | Cerebral aneurysm (HP:0004944) | 2.01626446 |
| 77 | Aortic aneurysm (HP:0004942) | 2.01286373 |
| 78 | B lymphocytopenia (HP:0010976) | 2.00636145 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.00636145 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00382751 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00382751 |
| 82 | Abnormality of T cell number (HP:0011839) | 1.99416409 |
| 83 | Increased IgE level (HP:0003212) | 1.99409190 |
| 84 | Vasculitis (HP:0002633) | 1.99164382 |
| 85 | Epistaxis (HP:0000421) | 1.99088922 |
| 86 | Premature rupture of membranes (HP:0001788) | 1.98402401 |
| 87 | IgG deficiency (HP:0004315) | 1.98310192 |
| 88 | Broad face (HP:0000283) | 1.97388123 |
| 89 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.96066369 |
| 90 | Hematochezia (HP:0002573) | 1.95281711 |
| 91 | Short nail (HP:0001799) | 1.95281023 |
| 92 | Onycholysis (HP:0001806) | 1.94577473 |
| 93 | Papilloma (HP:0012740) | 1.93421065 |
| 94 | Verrucae (HP:0200043) | 1.93421065 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 1.93276576 |
| 96 | Poikiloderma (HP:0001029) | 1.93085068 |
| 97 | Combined immunodeficiency (HP:0005387) | 1.92854099 |
| 98 | Type I transferrin isoform profile (HP:0003642) | 1.92259062 |
| 99 | Emphysema (HP:0002097) | 1.91840114 |
| 100 | Fatigue (HP:0012378) | 1.91443923 |
| 101 | Periodontitis (HP:0000704) | 1.90426839 |
| 102 | Hypergammaglobulinemia (HP:0010702) | 1.89175914 |
| 103 | Aortic dissection (HP:0002647) | 1.88743418 |
| 104 | Increased mean platelet volume (HP:0011877) | 1.88334422 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 1.88205990 |
| 106 | Peritonitis (HP:0002586) | 1.87969287 |
| 107 | Autoimmune hemolytic anemia (HP:0001890) | 1.87661377 |
| 108 | Menorrhagia (HP:0000132) | 1.86670852 |
| 109 | Eosinophilia (HP:0001880) | 1.86668010 |
| 110 | Radial bowing (HP:0002986) | 1.86573010 |
| 111 | Joint stiffness (HP:0001387) | 1.86023496 |
| 112 | Increased serum pyruvate (HP:0003542) | 1.85855582 |
| 113 | Granulocytopenia (HP:0001913) | 1.85210030 |
| 114 | Hypertriglyceridemia (HP:0002155) | 1.85019393 |
| 115 | Ankle contracture (HP:0006466) | 1.84891752 |
| 116 | Mucopolysacchariduria (HP:0008155) | 1.84202059 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84202059 |
| 118 | Entropion (HP:0000621) | 1.83035743 |
| 119 | IgA deficiency (HP:0002720) | 1.82921762 |
| 120 | Colitis (HP:0002583) | 1.82618831 |
| 121 | Polycythemia (HP:0001901) | 1.81153613 |
| 122 | Glomerulopathy (HP:0100820) | 1.80275392 |
| 123 | Gastrointestinal stroma tumor (HP:0100723) | 1.79662459 |
| 124 | Skin rash (HP:0000988) | 1.79635542 |
| 125 | 11 pairs of ribs (HP:0000878) | 1.79443979 |
| 126 | Lymphoma (HP:0002665) | 1.78988341 |
| 127 | Beaking of vertebral bodies (HP:0004568) | 1.78786519 |
| 128 | Axonal loss (HP:0003447) | 1.78543011 |
| 129 | Abnormality of glycolysis (HP:0004366) | 1.77972269 |
| 130 | Acute hepatic failure (HP:0006554) | 1.77131041 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.77052076 |
| 132 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76731589 |
| 133 | Macrocytic anemia (HP:0001972) | 1.76385542 |
| 134 | Bicuspid aortic valve (HP:0001647) | 1.73644090 |
| 135 | Cholelithiasis (HP:0001081) | 1.73258750 |
| 136 | Purpura (HP:0000979) | 1.72775521 |
| 137 | Abnormality of the tricuspid valve (HP:0001702) | 1.72732874 |
| 138 | Distal lower limb muscle weakness (HP:0009053) | 1.71560052 |
| 139 | Gastrointestinal dysmotility (HP:0002579) | 1.71504247 |
| 140 | Prolonged neonatal jaundice (HP:0006579) | 1.70891985 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.69711047 |
| 142 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.69189802 |
| 143 | Stomatitis (HP:0010280) | 1.68461392 |
| 144 | Glucose intolerance (HP:0000833) | 1.68094403 |
| 145 | Ileus (HP:0002595) | 1.66377479 |
| 146 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65730910 |
| 147 | Achilles tendon contracture (HP:0001771) | 1.63750411 |
| 148 | Anorexia (HP:0002039) | 1.63170612 |
| 149 | Encephalitis (HP:0002383) | 1.61931298 |
| 150 | Oral leukoplakia (HP:0002745) | 1.61909930 |
| 151 | Chest pain (HP:0100749) | 1.61395104 |
| 152 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.61221507 |
| 153 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.61136004 |
| 154 | Upper limb muscle weakness (HP:0003484) | 1.59900883 |
| 155 | J-shaped sella turcica (HP:0002680) | 1.58262038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.33094139 |
| 2 | NME2 | 2.80718060 |
| 3 | EEF2K | 2.77785901 |
| 4 | VRK2 | 2.71523384 |
| 5 | TRIB3 | 2.43684670 |
| 6 | PIM2 | 2.36096499 |
| 7 | ERN1 | 2.34385401 |
| 8 | PKN2 | 2.29594969 |
| 9 | LRRK2 | 2.25790621 |
| 10 | KIT | 2.19295456 |
| 11 | TESK2 | 2.16815215 |
| 12 | BLK | 2.14928809 |
| 13 | KDR | 2.12001140 |
| 14 | STK10 | 2.06881205 |
| 15 | TBK1 | 2.03831905 |
| 16 | ZAP70 | 1.98464788 |
| 17 | TESK1 | 1.78813358 |
| 18 | RIPK4 | 1.78796596 |
| 19 | JAK3 | 1.74672170 |
| 20 | TYK2 | 1.73608404 |
| 21 | RPS6KA4 | 1.73389765 |
| 22 | BTK | 1.72657403 |
| 23 | MAP3K10 | 1.66147951 |
| 24 | TGFBR2 | 1.63814385 |
| 25 | SCYL2 | 1.50445352 |
| 26 | RPS6KB2 | 1.49808613 |
| 27 | TEC | 1.49771568 |
| 28 | MST1R | 1.49315357 |
| 29 | TAOK2 | 1.48646174 |
| 30 | FLT3 | 1.47698910 |
| 31 | MAP2K3 | 1.45930452 |
| 32 | PAK4 | 1.44151525 |
| 33 | TGFBR1 | 1.42035922 |
| 34 | MAPKAPK3 | 1.38944614 |
| 35 | TXK | 1.38692229 |
| 36 | ARAF | 1.36038256 |
| 37 | CSF1R | 1.35960024 |
| 38 | BCKDK | 1.35464225 |
| 39 | TTN | 1.29896909 |
| 40 | IKBKE | 1.26069101 |
| 41 | PBK | 1.25259368 |
| 42 | SMG1 | 1.22638359 |
| 43 | BUB1 | 1.21137799 |
| 44 | NEK2 | 1.20299223 |
| 45 | SYK | 1.08475265 |
| 46 | MST4 | 1.06627965 |
| 47 | ITK | 1.05951718 |
| 48 | PIM1 | 1.05867473 |
| 49 | PRPF4B | 1.05497639 |
| 50 | PTK6 | 1.05037557 |
| 51 | ABL2 | 1.02058911 |
| 52 | IKBKB | 1.01558342 |
| 53 | MAP3K11 | 1.00801405 |
| 54 | NEK1 | 1.00004144 |
| 55 | MATK | 0.97683965 |
| 56 | PDK2 | 0.96781118 |
| 57 | WEE1 | 0.96662339 |
| 58 | ILK | 0.95746374 |
| 59 | MAP3K8 | 0.94913462 |
| 60 | TRPM7 | 0.94394292 |
| 61 | LCK | 0.93553018 |
| 62 | GRK6 | 0.93516977 |
| 63 | MAP3K3 | 0.93414769 |
| 64 | IRAK4 | 0.92175374 |
| 65 | EIF2AK1 | 0.87562759 |
| 66 | HCK | 0.87399517 |
| 67 | LYN | 0.87057579 |
| 68 | CSK | 0.85575664 |
| 69 | SRPK1 | 0.83535481 |
| 70 | BMPR2 | 0.82792106 |
| 71 | BRSK2 | 0.82226165 |
| 72 | NEK9 | 0.79971258 |
| 73 | LMTK2 | 0.79957997 |
| 74 | FGFR4 | 0.76213430 |
| 75 | PASK | 0.75782991 |
| 76 | SIK3 | 0.75042373 |
| 77 | DAPK1 | 0.74305135 |
| 78 | JAK1 | 0.74259826 |
| 79 | MAP3K14 | 0.74120891 |
| 80 | CDC7 | 0.73795784 |
| 81 | CLK1 | 0.71893728 |
| 82 | LIMK1 | 0.71713484 |
| 83 | PAK2 | 0.70041062 |
| 84 | PRKG2 | 0.69613401 |
| 85 | ACVR1B | 0.69369155 |
| 86 | ICK | 0.69242657 |
| 87 | ERBB4 | 0.68753924 |
| 88 | AURKA | 0.67084878 |
| 89 | CDK6 | 0.66477049 |
| 90 | CCNB1 | 0.65744360 |
| 91 | EPHB1 | 0.65723259 |
| 92 | AURKB | 0.65176434 |
| 93 | EIF2AK3 | 0.65123402 |
| 94 | CDK4 | 0.65079627 |
| 95 | STK4 | 0.64567535 |
| 96 | GRK7 | 0.63782854 |
| 97 | EPHA2 | 0.62584675 |
| 98 | MAPKAPK2 | 0.62579531 |
| 99 | FES | 0.61318699 |
| 100 | NLK | 0.59566411 |
| 101 | CHUK | 0.57629578 |
| 102 | RIPK1 | 0.57553552 |
| 103 | DYRK3 | 0.56740999 |
| 104 | CDK7 | 0.55396994 |
| 105 | BRAF | 0.54098761 |
| 106 | TAOK3 | 0.52568214 |
| 107 | MAP3K1 | 0.52060390 |
| 108 | MAP3K6 | 0.50554895 |
| 109 | DYRK1B | 0.50411603 |
| 110 | RAF1 | 0.49806624 |
| 111 | MYLK | 0.49458359 |
| 112 | TLK1 | 0.47836179 |
| 113 | DAPK3 | 0.46651520 |
| 114 | MAP2K6 | 0.45520615 |
| 115 | CDK8 | 0.45266142 |
| 116 | IRAK3 | 0.42555353 |
| 117 | MOS | 0.41245651 |
| 118 | BMX | 0.40634672 |
| 119 | CAMKK2 | 0.40098925 |
| 120 | ATR | 0.40036699 |
| 121 | PAK1 | 0.39673337 |
| 122 | RPS6KA6 | 0.39659474 |
| 123 | TTK | 0.39398482 |
| 124 | MAP3K12 | 0.39060904 |
| 125 | PTK2 | 0.38034259 |
| 126 | MAPK11 | 0.37698181 |
| 127 | TIE1 | 0.37228410 |
| 128 | BRSK1 | 0.36960603 |
| 129 | VRK1 | 0.35921723 |
| 130 | STK16 | 0.35817313 |
| 131 | JAK2 | 0.35551221 |
| 132 | PIK3CG | 0.35355997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.00972233 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.78132707 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54291854 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16843233 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12053194 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 1.83496183 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.82101285 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75897846 |
| 9 | Shigellosis_Homo sapiens_hsa05131 | 1.74978129 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.74338191 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.73065911 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71917570 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.70516815 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62545179 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61065263 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.59061344 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55942109 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55629083 |
| 19 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.52685430 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51789600 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50242600 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48864152 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.48767025 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.46515357 |
| 25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.44946315 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40231817 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39933467 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39398959 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.37192099 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35206907 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35164996 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35116346 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.33369588 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33124607 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32358812 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32113670 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.32083296 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29390547 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29116200 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28029043 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27030396 |
| 42 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23892939 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22277205 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.22045502 |
| 45 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.20842476 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.19942935 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18967598 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17997640 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.17848843 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.11726232 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.10356296 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08881585 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07878175 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07670081 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07428183 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.07160110 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.05632783 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03807201 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 1.01580639 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 1.00527902 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99883921 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99816140 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99334408 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99017709 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98868983 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98672413 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98033966 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97607454 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97175712 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97064883 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.96310042 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92509727 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91782755 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89714363 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88729711 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87636744 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87506227 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85516334 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.85061760 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85029839 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82181063 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81577138 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.81398020 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79672333 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78188208 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77988689 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77976463 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.76700875 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74060661 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72778904 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.71934097 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71227334 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70781712 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.70138695 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70100127 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69260283 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69053734 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.67714751 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65555159 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64523279 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64141518 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64116859 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.63478415 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62403623 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.62216474 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62113467 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61970680 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61890461 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61112106 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61051261 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59657407 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56624499 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54732520 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53792018 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53589307 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.53313830 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53220055 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53125078 |
| 119 | RNA polymerase_Homo sapiens_hsa03020 | 0.52830324 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51992783 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51118405 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50832258 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49834740 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44744642 |
| 125 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44647643 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43339797 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.41653142 |

